ஷாங்காய் சர்வதேச குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஷாங்காய் சர்வதேச குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஷாங்காய் சர்வதேச குழு Today - Breaking & Trending Today

Chinese chip developer SemiDrive nets nearly $154m in Series B round


Chinese chip developer SemiDrive nets nearly $154m in Series B round
Source: Brian Kostiuk/Unsplash
July 26, 2021
Chinese automotive system-on-chip (SoC) product startup Nanjing SemiDrive Technology Co, Ltd has secured nearly 1 billion yuan ($154 million) in a Series B round, the investee announced on Monday. 
In the statement, it said that the fresh round was co-led by state-owned China Development Bank Capital’s joint fund and smart manufacturing-focused V Fund. 
The round saw participation from a slew of state-backed investors including Bank of China’s overseas investment unit BOC International, Shanghai International Group’s Shanghai Technology Innovation Investment Fund and Shanghai-based Zhangjiang Group’s sub-fund.  ....

Jason Zhang , Maggie Qiu , Semidrive Technology Co Ltd , Zhangjiang Group , Cv Fund , Group Corporation , China Development Bank Capital , Walden International , Shanghai International Group , Shanghai Technology Innovation Investment Fund , Shanghai Based Zhangjiang Group , Matrix Partners China , Vertex Ventures China , Fanzhuo Capital , Sequoia Capital China , Lenovo Capital , Accurate Capital , China Automotive , Lanpu Capital , Vinno Capital , Shanghai Based Cantor Jungle , ஜேசன் ஜாங் , மாகி கீயூ , வ் நிதி , குழு நிறுவனம் , சீனா வளர்ச்சி வங்கி மூலதனம் ,

Chinese data analytics firm Kyligence bags $70m in Series D round


Chinese data analytics firm Kyligence bags $70m in Series D round
April 21, 2021
Chinese data analytics firm Kyligence Inc has raised $70 million in its Series D round of funding led by Shanghai Pudong Development Bank’s offshore investment bank SPDB International. 
CICC Capital’s sub-fund along with wealth management player Gopher Asset Management, state-backed Shanghai International Group’s funds of funds Guofang, American family office ASG, Jumbo Sheen Fund, and Shanghai Trust’s Puxin Capital joined the latest round.
Return backers – Shunwei Capital, Redpoint China Ventures and Eight Roads – made a follow-on investment in the Series D round. The three investors had partnered with Coatue Management to inject $25 million in Kyligence’s Series C round in 2019. ....

Guo Fang , United States , Shanghai Trust Puxin Capital , Jumbo Sheen Fund , Kyligence Inc , Shanghai Pudong Development Bank , Ping An Bank , Shanghai International Group , Gopher Asset Management , Shanghai Trust , Puxin Capital , Shunwei Capital , Redpoint China Ventures , Eight Roads , Coatue Management , Apache Kylin , San Jose , China Unionpay , கூவோ ஃப்யாஂக் , ஒன்றுபட்டது மாநிலங்களில் , பிங் ஒரு வங்கி , ஷாங்காய் சர்வதேச குழு , கோபேர் சொத்து மேலாண்மை , ஷாங்காய் நம்பிக்கை , ரேடபோய்ன்த் சீனா முயற்சிகள் , எட்டு சாலைகள் ,

Chinese online pharmacy SPH gathers $159.7m in Series B round


Chinese online pharmacy SPH gathers $159.7m in Series B round
Visual from Shanghai Pharmaceuticals website.
February 18, 2021
SPH Health Commerce, a Chinese Internet hospital and online pharmacy, has completed its Series B round of financing at 1.033 billion yuan ($159.7 million).
With this, the company will not be a controlled subsidiary of the country’s drug developer and distributor Shanghai Pharmaceuticals.
Shanghai-based SPH, which was founded in March 2015 by Shanghai Pharma, saw the stake held by the parent reduce to nearly 48% from 72.7% after the transaction, SPH announced in a statement on Thursday.
The billion-yuan investment was completed on January 18. As a result of the new financing, Hong Kong and Shanghai-listed Shanghai Pharma will no longer consolidate the financials of SPH into its financial statements. ....

Hong Kong , Shanghai Pharmaceuticals , Shanghai Charity Foundation , Shanghai Biomedical Industrial Equity Investment Fund , Valliance Capital , Sph Health Commerce , Shanghai International Group , Chinese Internet , Shanghai Pharma , Shanghai Listed Pharma , Shanghai City , China Jianyin , New Alliance Capital , Ample Harvest Finance , Xinte Pharmaceutical Chain , Cardinal China , Cardinal Health , Softbank China Venture Capital , ஹாங் காங் , ஷாங்காய் மருந்துகள் , ஷாங்காய் தொண்டு அடித்தளம் , ஷாங்காய் உயிர் மருத்துவ தொழில்துறை பங்கு முதலீடு நிதி , கூட்டணி மூலதனம் , ஷாங்காய் சர்வதேச குழு , சீன இணையதளம் , ஷாங்காய் பார்மா ,

China Digest: Sequoia backs Neurophth; TransThera bags over $50m


China Digest: Sequoia backs Neurophth; TransThera bags over $50m
February 9, 2021
Wuhan Neurophth Biological Technology has secured 400 million yuan ($62 million) in a Series B round of financing jointly led by Guofang FOF and InnoVision Capital, while Nanjing TransThera Biosciences has garnered over $50 million led by Co-Stone Asset Management.
Sequoia backs gene therapy company Neurophth
Chinese ophthalmic gene therapy technology company Wuhan Neurophth Biological Technology Co., Ltd has secured 400 million yuan ($62 million) in a Series B round of financing, according to a company statement on Tuesday.
The fresh round was co-led by Shanghai International Group’s Guofang FOF and Greater China-focused PE firm InnoVision Capital, while new investors including Oriza Holdings, Grand Mount Capital, and Yuanfeng Capital joined the round. ....

Guo Fang , China General , Transthera Biosciences , Wuhan Neurophth Biological Technology , Fosun Group Innostar Capital , Fund Management , Korean Lg Chem Life Sciences , Oriza Holdings , Shanghai International Group Guofang , Transthera Biosciences Co Ltd , Wuhan Neurophth Biological Technology Co Ltd , National Medical Products Administration , Teijin Group , China Merchants Group , Innovision Capital , Nanjing Transthera Biosciences , Co Stone Asset , Shanghai International Group , Greater China Focused , Grand Mount Capital , Yuanfeng Capital , Sequoia Capital China , Northern Light Venture Capital , Northern Light , Fosun Group , Innostar Capital ,